SCHEMBL23905792

SCHEMBL23905792

COc1cc(C(=O)NF)cc2cc(C)nnc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.44
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
RXFP1 Q9HBX9 2/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
HPGDS O60760 1/20 0.39
HPGD P15428 4/20 0.37
KDM4E B2RXH2 1/20 0.37
RAB9A P51151 2/20 0.36
LMNA P02545 1/20 0.35
ALDH1A1 P00352 2/20 0.35
F2 P00734 1/20 0.35
PLAU P00749 1/20 0.35
KLKB1 P03952 1/20 0.35
ELANE P08246 1/20 0.35
SIRT5 Q9NXA8 1/20 0.35
NPC1 O15118 1/20 0.34
MAPT P10636 1/20 0.34
ABCB1 P08183 1/20 0.34
ABCC1 P33527 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23904746 0.87 HPGDS (0.51) POLBMEN1KMT2ARXFP1SMN1; SMN2
SCHEMBL23905572 0.84 KDM4E (0.47) POLBMEN1KMT2ARXFP1HPGDS
SCHEMBL23904867 0.84 MEN1 (0.48) POLBMEN1KMT2ARXFP1SMN1; SMN2
SCHEMBL23905617 0.82 LMNA (0.50) POLBMEN1KMT2ASMN1; SMN2HPGDS
SCHEMBL23904745 0.82 CA12 (0.50) POLBKDM4ERAB9ALMNAF2
SCHEMBL23958791 0.82 KMT2A (0.52) POLBMEN1KMT2ARXFP1SMN1; SMN2
SCHEMBL30007169 0.81 TSHR (0.45) POLBSMN1; SMN2HPGDSHPGDKDM4E
SCHEMBL23930220 0.75 KDM4E (0.44) POLBMEN1KMT2ARXFP1HPGDS
SCHEMBL30211289 0.75 KDM4E (0.44) POLBMEN1KMT2ARXFP1HPGDS
SCHEMBL23930093 0.73 CA12 (0.39) POLBSMN1; SMN2KDM4ERAB9AF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021198981-A1 ANTIVIRAL COMPOUNDS AND USES THEREOF Janssen Biopharma, Inc. (US) 2021-10-07 WO disclosed